Results 31 to 40 of about 61,568 (292)

Cancer in myositis

open access: yesIndian Journal of Rheumatology, 2020
There is an intriguing relationship between cancer and myositis. The immunosuppressive agents commonly used to treat myositis patients are known to favor the development of cancer, but this factor does not seem to be the main cause of the association ...
Albert Selva-O'Callaghan   +3 more
doaj   +1 more source

Inclusion body myositis

open access: yesDefinitions, 2019
Inclusion body myositis (IBM) is the most common subtype of autoimmune myopathy in patients older than the age of 50 years. Several diagnostic criteria have been proposed for IBM based on expert opinion and consensus groups.
Sreelakshmi Panginikkod, Rina Musa
semanticscholar   +1 more source

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

open access: yesJAMA Neurology, 2018
Importance Idiopathic inflammatory myopathies are heterogeneous in their pathophysiologic features and prognosis. The emergence of myositis-specific autoantibodies suggests that subgroups of patients exist.
K. Mariampillai   +11 more
semanticscholar   +1 more source

Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study

open access: yesPediatric Rheumatology Online Journal, 2017
Objective A pilot study to determine endothelial progenitor cells (EPC) number in children with Juvenile Dermatomyositis (JDM). Methods After obtaining informed consent, the EPC number from 34 fasting children with definite/probable JDM at various stages
Dong Xu   +4 more
doaj   +1 more source

Cutaneous manifestations in idiopathic inflammatory myopathies

open access: yesJournal of IMIDs, 2022
Idiopathic inflammatory myopathies (IIMs), also known as autoimmune myositis, are a rare group of autoimmune disorders with a heterogenoeous spectrum of muscular and extramuscular involvement. IIM can be classified into several subgroups: dermatomyositis
Juan Sanz-Correa   +2 more
doaj   +1 more source

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity

open access: yesRheumatology, 2020
Objectives In order to address the reliability of commercial assays to identify myositis-specific and -associated autoantibodies, we aimed to compare the results of two commercial immunoassays with the results obtained by protein immunoprecipitation ...
S. Tansley   +3 more
semanticscholar   +1 more source

Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis

open access: yesClinical Rheumatology, 2021
We analyzed the prevalence of anti-mitochondrial autoantibodies (AMA) in adult- and juvenile-onset myositis longitudinal cohorts and investigated phenotypic differences in myositis patients with AMA.
S. Sabbagh   +13 more
semanticscholar   +1 more source

Exercise in Myositis [PDF]

open access: yesCurrent Treatment Options in Rheumatology, 2018
A growing body of evidence supports exercise as a very important part of the treatment for adult patients with idiopathic inflammatory myopathies (IIM). This review mainly focuses on exercise studies published during the last 2 years in adult myositis.During the last couple of years, new publications present further evidence for intensive endurance ...
openaire   +3 more sources

Myositis Ossificans Traumatica of the Temporal Muscle: a Case Report and Literature Review Emphasizing Radiographic Features on Computed Tomography and Magnetic Resonance Imaging

open access: yeseJournal of Oral Maxillofacial Research, 2019
Objectives: Heterotopic bone formation within a muscle is designated as ‘myositis ossificans’, and it is associated with multiple aetiologies, such as trauma, genetic predisposition, post-infection, or undetermined causes.
Erika Antonia dos Anjos Ramos   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy